Results 1 to 10 of about 87,517 (311)
Fluoxetine Potentiates Phagocytosis and Autophagy in Microglia
Fluoxetine is a classic antidepressant drug, and its immunomodulatory effects have recently been reported in many disease models. In addition, it has strong antineuroinflammatory effects in stroke and neurodegenerative animal models.
Sung Hee Park+5 more
doaj +1 more source
Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition
Fluoxetine is still one of the most widely used antidepressants in the world. The drug is extensively metabolized by several cytochrome P450 (CYP450) enzymes and subjected to a myriad of CYP450-mediated drug interactions.
Malavika Deodhar+4 more
doaj +1 more source
Analysis of Adherence to Fluoxetine Treatment through its Plasma Concentration
Depression plays an important role in non-adherence to medical recommendations. Fluoxetine is a first line of depression treatment. This study aimed to evaluate adherence to drug therapy in fluoxetine users by different methods. A cross-section study was
Juliana Raquel Raasch+8 more
doaj +1 more source
Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. [PDF]
The selective serotonin reuptake inhibitor (SSRI) Prozac® (fluoxetine) is the only registered antidepressant to treat depression in children and adolescents.
Judith R Homberg+8 more
doaj +1 more source
Fluoxetine, one of the latest clinical antidepressants, is reported to have the anti-proliferative effect on cancer cells via immune-related pathways. However, the mechanism is still not known.
Shali Shao+3 more
doaj +1 more source
Depression is one of the most prevalent mental disorders associated with reductions in bone mineral density and increased fracture risk. Fluoxetine is a highly prescribed selective serotonin reuptake inhibitor (SSRI) in the treatment of depression and is
Raymond W. Lam+6 more
doaj +1 more source
Over the last few years, fluoxetine has been one of the most prescribed medications for the treatment of diverse psychiatric conditions in Mexico.
Julia Sagahón‐Azúa+5 more
doaj +1 more source
Pharmacogenetics of fluoxetine
There is a number of antidepressants (ADs) which prevent reabsorption of neurotransmitters in the body. Known together as reuptake inhibitors, they prevent the reuptake of one or some neurotransmitters so that the majority of them is present and active in the brain.
S. D. Skopin+2 more
openaire +3 more sources
This study reports the antiviral activity of the drug fluoxetine against some enteroviruses (EV). We had previously established a model of persistent coxsackievirus B4 (CVB4) infection in pancreatic cell cultures and demonstrated that fluoxetine could ...
Enagnon Kazali Alidjinou+5 more
doaj +1 more source
Corticosterone facilitates fluoxetine-induced neuronal plasticity in the hippocampus. [PDF]
The hippocampal dentate gyrus has been implicated in a neuronal basis of antidepressant action. We have recently shown a distinct form of neuronal plasticity induced by the serotonergic antidepressant fluoxetine, that is, a reversal of maturation of the ...
Katsunori Kobayashi+5 more
doaj +1 more source